Key benefits of large-scale use of universal over conventional flu vaccines

December 15, 2016, Public Library of Science

Universal vaccines that protect against multiple strains of influenza virus at once could offer key population-level benefits over conventional seasonal vaccines, according to a new study published in PLOS Computational Biology.

Flu-causing viruses are continually evolving. To keep up, scientists must update vaccines regularly so that people can be protected against whichever seasonal pose the greatest risk. However, researchers are working to develop universal vaccines that could protect against multiple flu strains without needing to be updated.

Research on universal flu vaccines has mostly focused on their potential effects in individual patients. To better understand their effects at the population level, Rahul Subramanian of The University of Chicago and colleagues mathematically modeled the interactions between vaccination, , and flu virus evolution.

The model revealed that deployment of universal vaccines across large populations could reduce flu transmission more efficiently than conventional vaccines. It could also slow the evolution of new strains of and bolster herd immunity, protecting against the emergence of especially dangerous pandemic strains.

"New influenza vaccines could, for the first time, maintain their effectiveness in the face of viral evolution," Subramanian says. "In doing so they could transform the way we manage influenza in future."

However, conventional vaccines that are well-matched against circulating flu strains are highly effective and are likely to continue to play an important role. Subramanian says that an optimal approach may be to strategically use universal vaccines alongside conventional vaccines to protect at-risk groups while controlling transmission in the whole population.

Explore further: UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

More information: Subramanian R, Graham AL, Grenfell BT, Arinaminpathy N (2017) Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines. PLoS Comput Biol 13(1): e1005204. DOI: 10.1371/journal.pcbi.1005204

Related Stories

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

March 29, 2016
Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

New, more effective strategy for producing flu vaccines

December 5, 2016
A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines ...

Study suggests potential hurdle to universal flu vaccine development may be overcome

August 15, 2012
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...

Stepping closer to a universal flu vaccine

October 7, 2016
Researchers at McMaster University and two American universities have taken another step closer to developing a much more effective, "one-punch" universal flu vaccine.

A new approach to predict evolution of influenza viruses can enhance vaccine efficacy

December 7, 2015
New results from a study performed at the University of Helsinki suggest that genomic information from circulating influenza viruses can help in producing more efficient seasonal vaccines. The researchers were able to develop ...

Intranasal flu vaccine produces long-lasting immune response in mice

July 19, 2016
Intranasal flu vaccines may be able to provide long-lasting protection against pandemic flu strains, according to a new study from immunologists at Columbia University Medical Center (CUMC).

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.